ENDRA Life Sciences (NDRA) versus Digirad (DRAD) Head-To-Head Contrast

Share on StockTwits

ENDRA Life Sciences (NASDAQ:NDRA) and Digirad (NASDAQ:DRAD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk.

Analyst Recommendations

This is a breakdown of current ratings and target prices for ENDRA Life Sciences and Digirad, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ENDRA Life Sciences 0 0 0 0 N/A
Digirad 0 0 0 0 N/A

Valuation & Earnings

This table compares ENDRA Life Sciences and Digirad’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ENDRA Life Sciences $350,000.00 38.45 -$5.37 million N/A N/A
Digirad $118.34 million 0.13 -$35.73 million N/A N/A

ENDRA Life Sciences has higher earnings, but lower revenue than Digirad.

Profitability

This table compares ENDRA Life Sciences and Digirad’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ENDRA Life Sciences N/A -394.07% -266.99%
Digirad -18.00% -15.04% -7.26%

Volatility & Risk

ENDRA Life Sciences has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Digirad has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500.

Institutional and Insider Ownership

12.7% of ENDRA Life Sciences shares are held by institutional investors. Comparatively, 49.7% of Digirad shares are held by institutional investors. 12.7% of ENDRA Life Sciences shares are held by insiders. Comparatively, 9.1% of Digirad shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Dividends

Digirad pays an annual dividend of $0.17 per share and has a dividend yield of 23.0%. ENDRA Life Sciences does not pay a dividend. Digirad has increased its dividend for 2 consecutive years.

Summary

Digirad beats ENDRA Life Sciences on 7 of the 11 factors compared between the two stocks.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.

Digirad Company Profile

Digirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services. The Mobile Healthcare segment offers contract diagnostic imaging services, including computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment develops and sells gamma camera imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance services. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply